Changes in HIV Clinical Visit Frequency and Viral Suppression During and After COVID-19 Restrictions: A nested study within NA-ACCORD in the US, 2018–2021

Clicks: 6
ID: 327459
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #211 of 233 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 233 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Temporary COVID-19-related restrictions disrupted routine HIV care and viral load (VL) testing for people with HIV (PWH). Whether and when encounters and VL suppression returned to pre-pandemic levels remains unclear. We aimed to evaluate changes in HIV clinical encounters frequency and VL suppression from 2018 through 2021, and assess the impact of COVID-19 restriction policy. Methods Adults (≥18 years) with HIV from 12 U.S. clinical cohorts with ≥1 VL test from June 2020 to December 2021 were categorized into mutually exclusive HIV care groups: (1) in-care before restrictions, (2) new-to-care and (3) re-engaging during restrictions. Logistic regression with generalized estimating equations was used to estimate adjusted odds ratios (aOR) of unsuppressed VL (>200 copies/mL) for HIV care groups from June 2020 to December 2021. A linear mixed model evaluated associations between state-level COVID-19 policy strength (mild, moderate, or strong) and unsuppressed VL. Results Among PWH in-care (n=48,605), encounter frequency decreased sharply during early COVID-19 restrictions but returned to pre-pandemic levels by December 2020 and suppressed VL rate remained above 91%. New-to-care (n=105) or re-engaging (n=483) individuals did not increase odds of unsuppressed VL (vs. in-care, aOR=0.91 [95% CI: 0.73, 1.13]). Those living in states with strong (vs. mild, aOR=1.31 [0.93, 1.86]) COVID-19 restriction policies had increased odds of unsuppressed VL, though not significant. Conclusions HIV care encounters returned to pre-pandemic levels by late 2020, with sustained viral suppression. Prolonged COVID-19 restrictions were associated with higher risk of unsuppressed VL. HIV patients, providers, and clinics showed resilience during COVID-19 disruptions, offering lessons for future emergencies.
Reference Key
openalex_W7207661578 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yue Zhang, Brenna Hogan, Kelly A Gebo, Peter F. Rebeiro, Milton L. Wainberg, Catherine R. Lesko, Vincent C. Marconi, N Sarita Shah, Raynell Lang, Nel Jason Haw, Yawei Cheng, Michael A Horberg, Jennifer O. Lam, Michael J. Silverberg, George Yendewa, Joseph J Eron, Richard D. Moore, Angela M. Parcesepe, Keri N. Althoff, Constance A. Benson, Ronald J. Bosch, Gregory D. Kirk, Vincent C. Marconi, Jonathan Colasanti, Kenneth H Mayer, Kate Buchacz, Jun Li, Kelly A Gebo, Richard D. Moore, Richard D. Moore, George Yendewa, Michael A Horberg, Michael J Silverberg, Jennifer E. Thorne, Todd Brown, Phyllis Tien, Gypsyamber DʼSouza, Graham Smith, Mona Loutfy, Meenakshi Gupta, Marina B. Klein, Charles Rabkin, A Kroch, Ann Burchell, Adrian Betts, Joanne Lindsay, Ank Nijhawan, Ángel M. Mayor, M John Gill, Jeffrey N. Martin, Steven G. Deeks, Jun Li, John T. Brooks, Michael S. Saag, Michael J. Mugavero, Greer Burkholder, laura Bamford, Maile Karris, Joseph J Eron, Sonia Napravnik, Mari M. Kitahata, Heidi M Crane, Timothy R Sterling, David Haas, Peter Rebeiro, Megan Turner, Lesley Park, Kathleen McGinnis, Amy Justice, Keri N. Althoff, Richard D. Moore, Mari M. Kitahata, Catherine R. Lesko, Michael A Horberg, Marina B. Klein, Rosemary G. McKaig, Aimee Freeman, Keri N. Althoff, Richard D. Moore, Aimee Freeman, Mari M. Kitahata, Heidi M Crane, Joseph Delaney, Justin McReynolds, Justin McReynolds, William B Lober, Catherine R. Lesko, Sally B. Coburn, Brenna Hogan, Elizabeth Humes, Wendy (Chunyan) Zheng, Jason Haw, Yawei Cheng, Lucas Gerace
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag557
URL
https://doi.org/10.1093/ofid/ofag557
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.